INSMED INC Variable Lease, Payment
INSMED INC (INSM) reported Variable Lease, Payment of $7.00 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-17.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:VariableLeasePayment · last filed 2022-02-17
- INSMED INC variable lease, payment for fiscal 2021 was $7.00M, a 29.29% decline from fiscal 2020.
- INSMED INC variable lease, payment for fiscal 2020 was $9.90M, a 9800.00% increase from fiscal 2019.
- INSMED INC variable lease, payment for fiscal 2019 was $100.00K.
| Period end | Variable Lease, Payment 12 month |
|---|---|
| 2021-12-31 | $7.00M 10-K · filed 2022-02-17 |
| 2020-12-31 | $9.90M 10-K · filed 2022-02-17 |
| 2019-12-31 | $100.00K 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |